Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 27, 2020 - Issue 1
130
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Isolated light chain deposition disease neuropathy in a patient with multiple myeloma

ORCID Icon, ORCID Icon, , ORCID Icon, , , & ORCID Icon show all
Pages 67-68 | Received 06 Jun 2019, Accepted 16 Sep 2019, Published online: 28 Sep 2019

References

  • Jimenez-Zepeda VH. Light chain deposition disease: novel biological insights and treatment advances. Int J Lab Hematol. 2012;34(4):347–355.
  • Grassi MP, Clerici F, Perin C, et al. Light chain deposition disease neuropathy resembling amyloid neuropathy in a multiple myeloma patient. Ital J Neuro Sci. 1998;19(4):229–233.
  • Luigetti M, Frisullo G, Laurenti L, et al. Light chain deposition in peripheral nerve as a cause of mononeuritis multiplex in Waldenström’s macroglobulinaemia. J Neurol Sci. 2010;291(1–2):89–91.
  • Buxbaum JN, Chuba JV, Hellman GC, et al. Monoclonal immunoglobulin deposition disease: light chain and light and heavy chain deposition diseases and their relation to light chain amyloidosis. Clinical features, immunopathology, and molecular analysis. Ann Intern Med. 1990;112(6):455–464.
  • Popović M, Tavćar R, Glavač D, et al. Light chain deposition disease restricted to the brain: the first case report. Hum Pathol. 2007;38(1):179–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.